PATENT CLAIM ANALYSIS

Application Number: 15892302
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "212070"]

Abstract:
The present disclosure is concerned with benzo annulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 4):
The compound of  claim 1 , wherein R 2  is \u2014OR 20 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14380659', '14913266', '15039763', '15283508', '13329025']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7999247018683224
- 35 USC 102 Novelty (BERT): 0.5597882907113929
- Combined Prediction Score: 0.7759110607526295
- Mean Citation Score: 415.690416
- Max Citation Score: 428.13474
- Similarity Product: 328.8918739128506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test